Chembio Diagnostics, Inc. (CEMI) - Product Pipeline Analysis, 2014 Update

Date: December 9, 2014
Pages: 41
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CF1901459A5EN
Leaflet:

Download PDF Leaflet

Chembio Diagnostics, Inc. (CEMI) - Product Pipeline Analysis, 2014 Update
Summary

Chembio Diagnostics, Inc. (Chembio) together with its wholly owned subsidiary Chembio Diagnostic Systems, Inc., undertakes the development, manufacture and marketing of point-of-care diagnostic (POCs) tests that detect infectious diseases. The major commercially available products of the company include four rapid tests for the detection of HIV antibodies, two rapid tests for the detection of syphilis and a rapid test for the detection of canine leishmaniasis. Its new product pipeline is based on Dual Path Platform (DPP) technology. The company offers its products to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals and retailers. It also offers veterinary diagnostics. Chembio is headquartered in Medford, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Chembio Diagnostics, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Chembio Diagnostics, Inc. Company Snapshot
Chembio Diagnostics, Inc. Company Overview
Key Information
Chembio Diagnostics, Inc. Pipeline Products and Clinical Trials Overview
Chembio Diagnostics, Inc. – Pipeline Analysis Overview
Business Description
Key Facts
Chembio Diagnostics, Inc. - Major Products and Services
Chembio Diagnostics, Inc. Pipeline Products by Development Stage
Chembio Diagnostics, Inc. Clinical Trials by Trial Status
Chembio Diagnostics, Inc. Pipeline Products Overview
Battelle/CDC DPP Influenza Immunity Test
Battelle/CDC DPP Influenza Immunity Test Product Overview
Clearview HIV 1/2 STAT PAK Assay
Clearview HIV 1/2 STAT PAK Assay Product Overview
DPP Dengue Fever Assay
DPP Dengue Fever Assay Product Overview
DPP Ebola Test
DPP Ebola Test Product Overview
DPP Febrile Illness Multiplex Test
DPP Febrile Illness Multiplex Test Product Overview
DPP Hepatitis C Virus Assay
DPP Hepatitis C Virus Assay Product Overview
DPP HIV Oral Fluid Test CLIA Waived
DPP HIV Oral Fluid Test CLIA Waived Product Overview
DPP Leishmaniasis Rapid Diagnostic Test
DPP Leishmaniasis Rapid Diagnostic Test Product Overview
DPP Syphilis - HIV Test
DPP Syphilis - HIV Test Product Overview
DPP Syphilis - HIV Test Clinical Trial
DPP Syphilis Screen And Confirm Test
DPP Syphilis Screen And Confirm Test Product Overview
DPP Syphilis Screen And Confirm Test Clinical Trial
DPP Tuberculosis Assay
DPP Tuberculosis Assay Product Overview
Multiplex Influenza Immunity Test
Multiplex Influenza Immunity Test Product Overview
Point-of-Care Diagnostic Test - Specific Type Of Cancer
Point-of-Care Diagnostic Test - Specific Type Of Cancer Product Overview
Sure Check HIV OTC Assay
Sure Check HIV OTC Assay Product Overview
Chembio Diagnostics, Inc. - Key Competitors
Chembio Diagnostics, Inc. - Key Employees
Chembio Diagnostics, Inc. - Key Employee Biographies
Chembio Diagnostics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Chembio Diagnostics, Inc., Recent Developments
Nov 24, 2014: Chembio Signs Agreement With CDC Contractor to Develop a Multiplex Point-of-Care Test for Influenza Immunity
Oct 30, 2014: Chembio's DPP(R) HIV 1/2 Assay Receives CLIA Waiver From FDA
Oct 28, 2014: Chembio And Integrated BioTherapeutics To Develop Diagnostic Tests For Ebola And Febrile Illness
Oct 27, 2014: Chembio Partners With Integrated BioTherapeutics to Develop Point-of-Care Diagnostic Tests for Febrile Illness
Oct 27, 2014: Chembio Partners With Integrated BioTherapeutics to Develop Point-of-Care Diagnostic Tests for Ebola
Aug 07, 2014: Chembio Diagnostics Reports Second Quarter 2014 Financial Results
May 08, 2014: Chembio Diagnostics Reports First Quarter 2014 Financial Results
Apr 07, 2014: Chembio Terminates U.S. Distribution Agreement With Alere
Dec 02, 2013: Chembio Files for CLIA Waiver with FDA for Point-of-Care DPP(R) HIV 1/2 Assay
Nov 21, 2013: Chembio board member named winner of commercialization award by Purdue University
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Chembio Diagnostics, Inc., Key Facts
Chembio Diagnostics, Inc. Pipeline Products and Clinical Trials Overview
Chembio Diagnostics, Inc. Pipeline Products by Equipment Type
Chembio Diagnostics, Inc. Pipeline Products by Indication
Chembio Diagnostics, Inc. Clinical Trials by Trial Status
Chembio Diagnostics, Inc., Key Facts
Chembio Diagnostics, Inc., Major Products and Services
Chembio Diagnostics, Inc. Number of Pipeline Products by Development Stage
Chembio Diagnostics, Inc. Pipeline Products Summary by Development Stage
Chembio Diagnostics, Inc. Clinical Trials by Trial Status
Chembio Diagnostics, Inc. Clinical Trials Summary
Battelle/CDC DPP Influenza Immunity Test - Product Status
Battelle/CDC DPP Influenza Immunity Test - Product Description
Clearview HIV 1/2 STAT PAK Assay - Product Status
Clearview HIV 1/2 STAT PAK Assay - Product Description
DPP Dengue Fever Assay - Product Status
DPP Dengue Fever Assay - Product Description
DPP Ebola Test - Product Status
DPP Ebola Test - Product Description
DPP Febrile Illness Multiplex Test - Product Status
DPP Febrile Illness Multiplex Test - Product Description
DPP Hepatitis C Virus Assay - Product Status
DPP Hepatitis C Virus Assay - Product Description
DPP HIV Oral Fluid Test CLIA Waived - Product Status
DPP HIV Oral Fluid Test CLIA Waived - Product Description
DPP Leishmaniasis Rapid Diagnostic Test - Product Status
DPP Leishmaniasis Rapid Diagnostic Test - Product Description
DPP Syphilis - HIV Test - Product Status
DPP Syphilis - HIV Test - Product Description
DPP Syphilis - HIV Test - Behavioral Science Aspects of Rapid Test Acceptance
DPP Syphilis Screen And Confirm Test - Product Status
DPP Syphilis Screen And Confirm Test - Product Description
DPP Syphilis Screen And Confirm Test - Behavioral Science Aspects of Rapid Test Acceptance
DPP Tuberculosis Assay - Product Status
DPP Tuberculosis Assay - Product Description
Multiplex Influenza Immunity Test - Product Status
Multiplex Influenza Immunity Test - Product Description
Point-of-Care Diagnostic Test - Specific Type Of Cancer - Product Status
Point-of-Care Diagnostic Test - Specific Type Of Cancer - Product Description
Sure Check HIV OTC Assay - Product Status
Sure Check HIV OTC Assay - Product Description
Chembio Diagnostics, Inc., Key Employees
Chembio Diagnostics, Inc., Key Employee Biographies
Chembio Diagnostics, Inc., Subsidiaries

LIST OF FIGURES

Chembio Diagnostics, Inc. Pipeline Products by Equipment Type
Chembio Diagnostics, Inc. Pipeline Products by Development Stage
Chembio Diagnostics, Inc. Clinical Trials by Trial Status
Skip to top


Ask Your Question

Chembio Diagnostics, Inc. (CEMI) - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: